Craft

Navamedic

Stock Price

KR30.8

2024-10-29

Market Capitalization

KR544 M

2024-10-29

Revenue

KR565.4 M

FY, 2025

Navamedic Summary

Company Summary

Overview
Navamedic is a medtech and pharmaceutical products company which markets products to patients, hospitals and pharmacies. The Company operates through two segments, Pharma and Healthcare Products, and Medtech. Its product portfolio includes original and generic pharmaceuticals, as well as food supplements, medical devices, and other health care products. Navamedic also distributes medical nutrition products for various metabolic disorders.
Type
Public
Status
Active
Founded
2002
HQ
Oslo, NO | view all locations
Website
http://www.navamedic.com/
Cybersecurity rating
Sectors

Key People

  • Lars Hjarrand

    Lars Hjarrand, CFO

    • Terje Bakken

      Terje Bakken, Chairman

      • Kathrine Gamborg Andreassen

        Kathrine Gamborg Andreassen, CEO

      • Ole Henrik Eriksen

        Ole Henrik Eriksen, COO, Business Development

        LocationsView all

        4 locations detected

        • Oslo, Oslo HQ

          Norway

          Henrik Ibsens gate 90

        • Mölndal, Västra Götalands län

          Sweden

          Krokslätts parkgata 4

        • Sävedalen, Västra Götalands län

          Sweden

          Göteborgsvägen 74

        Navamedic Financials

        Summary Financials

        Revenue (Q1, 2026)
        kr137.9M
        Gross profit (Q1, 2026)
        kr54.4M
        Net income (Q1, 2026)
        (kr117.0K)
        Cash (Q1, 2026)
        kr67.1M
        EBIT (Q1, 2026)
        kr1.8M
        Enterprise value
        $681.7M

        Footer menu